Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,957 total articles

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Artelo Biosciences announced positive Phase 1 clinical trial results for ART26.12, their selective FABP5 inhibitor, demonstrating favorable safety, tolerability, and pharmacokinetics. Biomarker studies aided by AI identified potential indicators of target engagement, supporting further clinical development of ART26.12 for non-opioid treatment of ch…

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

Akari Therapeutics completed its previously announced private investment in public equity (PIPE) financing ahead of schedule, raising approximately $8.3 million in Q2 2026 including warrant exercises. The capital infusion strengthens the company's balance sheet as it prepares to advance its lead antibody drug conjugate (ADC) candidate, AKTX-101, in…

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

Polyrizon Ltd., a biotech company developing innovative intranasal hydrogels, has obtained central IRB approval to start its first human clinical trial testing NASARIX™, a nasal spray designed to block airborne allergens and manage seasonal allergic rhinitis. This regulatory milestone facilitates the progress of the trial aimed at evaluating the ef…

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

Alaunos Therapeutics reported new preclinical results from a diet-induced obesity mouse study of their investigational oral small-molecule ALN1003. The data demonstrate significantly lower liver weight after adjusting for body fat percentage, consistent with earlier findings of improved liver markers, reduced liver injury enzymes, favorable adipose…

AIB Data Centers Added to Russell Microcap® Index

AIB Data Centers Added to Russell Microcap® Index

AIB Data Centers Inc., focused on AI and HPC digital infrastructure, has been added to the Russell Microcap® Index as of June 29, 2026. This inclusion follows the company's recent name change and a successful $63.25 million public offering, enhancing its visibility among institutional investors as it expands its AI data center ecosystem.

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

Palisade Bio announced FDA clearance of the Investigational New Drug application for PALI-2108, enabling the start of a global Phase 2 clinical trial (ASCENTRA-UC) for treating moderately to severely active ulcerative colitis. The trial plans to enroll up to 204 patients across North America and Europe, with patient enrollment anticipated in late 2…

Cycurion, Inc. Enters into Asset Purchase Agreement to Acquire Kustom Entertainment’s Legacy Video Solutions Segment, Delivering Non-Dilutive Scale, Access to Approximately 1,000 New Clients and a Robust Portfolio of Approximately 58 Patents

Cycurion, Inc. Enters into Asset Purchase Agreement to Acquire Kustom Entertainment’s Legacy Video Solutions Segment, Delivering Non-Dilutive Scale, Access to Approximately 1,000 New Clients and a Robust Portfolio of Approximately 58 Patents

Cycurion, Inc. announced an asset purchase agreement to acquire Kustom Entertainment's video solutions division, including Digital Ally-branded video systems used by law enforcement. The acquisition is expected to close in early July 2026, adding approximately 1,000 new clients, a portfolio of 58 patents, $5.1 million in annual revenue, and $8 mill…

Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

Alliance Entertainment (Nasdaq: AENT) has broadened its Alliance Authentic preservation platform beyond vinyl records to include preserved Funko and Handmade by Robots collectibles. Each collectible is curated, numbered, limited, certified uncirculated, and NFC-secured to verify authenticity and ownership history, establishing a new category of per…

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Biodexa Pharmaceuticals PLC announced that Health Canada has approved the expansion of its Phase 3 Serenta trial for treating familial adenomatous polyposis (FAP) into Canada. This trial, already active in the US and Europe, aims to enroll 168 patients to evaluate eRapa, an mTOR inhibitor addressing an unmet therapeutic need for FAP. Enrollment acc…

Quantum Cyber Signs Definitive Agreements to Acquire U.S.-Based Manufacturing Facility in Bridgeport, Connecticut

Quantum Cyber Signs Definitive Agreements to Acquire U.S.-Based Manufacturing Facility in Bridgeport, Connecticut

Quantum Cyber announced definitive agreements to acquire a 50,000-square-foot manufacturing facility and equipment in Bridgeport, Connecticut, marking a strategic shift to become a vertically integrated autonomous defense manufacturer. This move aligns with U.S. national security priorities emphasizing domestic drone production and positions the co…

WeShop Added to Russell 3000® and Russell Microcap® Indexes

WeShop Added to Russell 3000® and Russell Microcap® Indexes

WeShop Holdings Limited (NASDAQ: WSHP), a community-owned social commerce platform, has been added to the Russell 3000 and Russell Microcap Indexes following FTSE Russell's annual reconstitution. This inclusion reflects the company's growth, enhances its visibility with institutional investors, and underscores its commitment to long-term shareholde…

Mingteng International Reaches New Milestone in Global Expansion with Overseas Orders Serving Markets in Serbia, Vietnam and Mexico

Mingteng International Reaches New Milestone in Global Expansion with Overseas Orders Serving Markets in Serbia, Vietnam and Mexico

Mingteng International Corporation Inc., a Nasdaq-listed automotive mold supplier based in China, announced purchase agreements with three overseas enterprises in Serbia, Vietnam, and Mexico. This marks a significant milestone in the company's global expansion strategy, particularly in the new energy vehicle (NEV) sector. These contracts strengthen…

Star Equity Holdings Added to the Russell Microcap® Index

Star Equity Holdings Added to the Russell Microcap® Index

Star Equity Holdings, Inc. announced its common stock has been added to the Russell Microcap® Index following the 2026 reconstitution, reflecting its growth in market capitalization and enhancing its exposure to institutional and microcap investors. The company is a diversified holding firm operating across building solutions, business services, en…

Stran Expands Strategic Casino Market Presence with Industry Veteran Kevin Lewis to Accelerate Growth and Client Impact

Stran Expands Strategic Casino Market Presence with Industry Veteran Kevin Lewis to Accelerate Growth and Client Impact

Stran & Company, Inc., a leading provider of outsourced marketing solutions, expanded its presence in the casino sector by adding Kevin Lewis as a contracted sales representative. Lewis brings significant experience and a $5M+ existing business portfolio in casino gifting and branded merchandise, particularly within the Las Vegas gaming market. His…

Achieve Life Sciences Joins Russell 2000® Index

Achieve Life Sciences Joins Russell 2000® Index

Achieve Life Sciences, a late-stage pharmaceutical company developing cytisinicline for nicotine dependence, has been included in the Russell 2000 and Russell 3000 indexes following the 2026 reconstitution. This inclusion reflects its market capitalization and may attract institutional investor attention. Cytisinicline, supported by Phase 3 clinica…